Cargando…

Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!

Introduction: Broad-spectrum beta-lactams are commonly prescribed for empirical or selective treatment of bacterial infections in children with malignancies. In the immunocompromised, appropriate concentration exposure is crucial to ensure antimicrobial efficacy. Augmented renal clearance (ARC) is i...

Descripción completa

Detalles Bibliográficos
Autores principales: André, Pascal, Diezi, Léonore, Dao, Kim, Crisinel, Pierre Alex, Rothuizen, Laura E., Chtioui, Haithem, Decosterd, Laurent Arthur, Diezi, Manuel, Asner, Sandra, Buclin, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785252/
https://www.ncbi.nlm.nih.gov/pubmed/35083184
http://dx.doi.org/10.3389/fped.2021.768438
_version_ 1784638922096115712
author André, Pascal
Diezi, Léonore
Dao, Kim
Crisinel, Pierre Alex
Rothuizen, Laura E.
Chtioui, Haithem
Decosterd, Laurent Arthur
Diezi, Manuel
Asner, Sandra
Buclin, Thierry
author_facet André, Pascal
Diezi, Léonore
Dao, Kim
Crisinel, Pierre Alex
Rothuizen, Laura E.
Chtioui, Haithem
Decosterd, Laurent Arthur
Diezi, Manuel
Asner, Sandra
Buclin, Thierry
author_sort André, Pascal
collection PubMed
description Introduction: Broad-spectrum beta-lactams are commonly prescribed for empirical or selective treatment of bacterial infections in children with malignancies. In the immunocompromised, appropriate concentration exposure is crucial to ensure antimicrobial efficacy. Augmented renal clearance (ARC) is increasingly recognized in this population, and raises concern for unmet concentration targets. We conducted a retrospective evaluation of meropenem and piperacillin exposure in our hospital's pediatric hematology-oncology patients. Materials and Methods: We compared trough levels of meropenem and piperacillin in a cohort of unselected pediatric hematology-oncology patients stratified based on their estimated renal function as decreased, normal or with ARC, and on their neutrophil count. Results: Thirty-two children provided a total of 51 meropenem and 76 piperacillin samples. On standard intermittent intravenous regimen, 67% of all trough plasma concentrations were below targeted concentrations. In neutropenic children with bacterial infection, all meropenem and 60% of piperacillin levels were below target. Nearly two-thirds of total samples came from children with ARC. In these patients, antimicrobial exposure was insufficient in 85% of cases (compared to 36% in the decreased or normal renal function groups), despite a dosage sometimes exceeding the maximum recommended daily dose. Under continuous infusion of piperacillin, only 8% of plasma levels were insufficient. Discussion: Intermittent administration of meropenem and piperacillin often fails to ensure sufficient concentration exposure in children treated for malignancies, even at maximal recommended daily dosage. This can in part be attributed to ARC. We recommend thorough assessment of renal function, resolute dosage adjustment, continuous infusion whenever possible and systematic therapeutic drug monitoring.
format Online
Article
Text
id pubmed-8785252
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87852522022-01-25 Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance! André, Pascal Diezi, Léonore Dao, Kim Crisinel, Pierre Alex Rothuizen, Laura E. Chtioui, Haithem Decosterd, Laurent Arthur Diezi, Manuel Asner, Sandra Buclin, Thierry Front Pediatr Pediatrics Introduction: Broad-spectrum beta-lactams are commonly prescribed for empirical or selective treatment of bacterial infections in children with malignancies. In the immunocompromised, appropriate concentration exposure is crucial to ensure antimicrobial efficacy. Augmented renal clearance (ARC) is increasingly recognized in this population, and raises concern for unmet concentration targets. We conducted a retrospective evaluation of meropenem and piperacillin exposure in our hospital's pediatric hematology-oncology patients. Materials and Methods: We compared trough levels of meropenem and piperacillin in a cohort of unselected pediatric hematology-oncology patients stratified based on their estimated renal function as decreased, normal or with ARC, and on their neutrophil count. Results: Thirty-two children provided a total of 51 meropenem and 76 piperacillin samples. On standard intermittent intravenous regimen, 67% of all trough plasma concentrations were below targeted concentrations. In neutropenic children with bacterial infection, all meropenem and 60% of piperacillin levels were below target. Nearly two-thirds of total samples came from children with ARC. In these patients, antimicrobial exposure was insufficient in 85% of cases (compared to 36% in the decreased or normal renal function groups), despite a dosage sometimes exceeding the maximum recommended daily dose. Under continuous infusion of piperacillin, only 8% of plasma levels were insufficient. Discussion: Intermittent administration of meropenem and piperacillin often fails to ensure sufficient concentration exposure in children treated for malignancies, even at maximal recommended daily dosage. This can in part be attributed to ARC. We recommend thorough assessment of renal function, resolute dosage adjustment, continuous infusion whenever possible and systematic therapeutic drug monitoring. Frontiers Media S.A. 2022-01-05 /pmc/articles/PMC8785252/ /pubmed/35083184 http://dx.doi.org/10.3389/fped.2021.768438 Text en Copyright © 2022 André, Diezi, Dao, Crisinel, Rothuizen, Chtioui, Decosterd, Diezi, Asner and Buclin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
André, Pascal
Diezi, Léonore
Dao, Kim
Crisinel, Pierre Alex
Rothuizen, Laura E.
Chtioui, Haithem
Decosterd, Laurent Arthur
Diezi, Manuel
Asner, Sandra
Buclin, Thierry
Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
title Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
title_full Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
title_fullStr Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
title_full_unstemmed Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
title_short Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
title_sort ensuring sufficient trough plasma concentrations for broad-spectrum beta-lactam antibiotics in children with malignancies: beware of augmented renal clearance!
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785252/
https://www.ncbi.nlm.nih.gov/pubmed/35083184
http://dx.doi.org/10.3389/fped.2021.768438
work_keys_str_mv AT andrepascal ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance
AT diezileonore ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance
AT daokim ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance
AT crisinelpierrealex ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance
AT rothuizenlaurae ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance
AT chtiouihaithem ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance
AT decosterdlaurentarthur ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance
AT diezimanuel ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance
AT asnersandra ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance
AT buclinthierry ensuringsufficienttroughplasmaconcentrationsforbroadspectrumbetalactamantibioticsinchildrenwithmalignanciesbewareofaugmentedrenalclearance